- Suzie ChenAssociate Professor, Chemical Biology, 164 Frelinghuysen Road, Piscataway, NJ 08854Interests: 50 publications, 29 grants, Editor of Frontiers in Bioscience
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.
- From existing therapies to novel targets: a current view on melanomaJin Namkoong, Jeffrey J Martino, Suzie ChenFront. Biosci. (Landmark Ed) 2006, 11(3), 2081–2092; https://doi.org/10.2741/19516Download7Citations30Views
- Cutaneous photoprotection and melanoma susceptibility: reaching beyond melanin content to the frontiers of DNA repairAna Luisa Kadekaro, Kazumasa Wakamatsu, Shosuke Ito, Zalfa A Abdel-MalekFront. Biosci. (Landmark Ed) 2006, 11(3), 2157–2173; https://doi.org/10.2741/19589Download30Citations14Views
- The current epidemiology of cutaneous malignant melanomaMarianne Berwick, Charles WigginsFront. Biosci. (Landmark Ed) 2006, 11(2), 1244–1254; https://doi.org/10.2741/187711Download57Citations209Views
- Molecular cytogenetic characterization of a novel cell line established from a superficial spreading melanomaAndrea Treszl, Andrea Ladanyi, Zsuzsa Rakosy, Zsuzsa Buczko, ... Margit BalazsFront. Biosci. (Landmark Ed) 2006, 11(2), 1844–1853; https://doi.org/10.2741/19272Download8Citations7Views
- The KISS1 metastasis suppressor: mechanistic insights and clinical utilityKevin T. Nash, Danny R. WelchFront. Biosci. (Landmark Ed) 2006, 11(1), 647–659; https://doi.org/10.2741/18244Download59Citations117Views
- Advances in malignant melanoma: genetic insights from mouse and manOmar Kabbarah, Lynda ChinFront. Biosci. (Landmark Ed) 2006, 11(1), 928–942; https://doi.org/10.2741/18493Download9Citations5Views
- Stromal responses in human primary melanoma of the skinLéon C.L. van Kempen, Goos N.P. van Muijen, Dirk J. RuiterFront. Biosci. (Landmark Ed) 2005, 10(3), 2922–2931; https://doi.org/10.2741/17481Download15Citations5Views
- The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanomaFriedegund Meier, Birgit Schittek, Silke Busch, Claus Garbe, ... Meenhard HerlynFront. Biosci. (Landmark Ed) 2005, 10(3), 2986–3001; https://doi.org/10.2741/175523Download195Citations119Views